NATIONAL TRENDS AND IN-HOSPITAL OUTCOMES OF EMERGENT TRANSCATHETER AORTIC VALVE REPLACEMENT AND BALLOON AORTIC VALVULOPLASTY IN PATIENTS WITH SEVERE AORTIC STENOSIS AND CARDIOGENIC SHOCK

Cardiogenic shock (CS) in severe aortic stenosis (AS) patients has a grave prognosis with > 50% in-hospital mortality. Balloon aortic valvuloplasty (BAV) is used as a bridge to aortic valve replacement (AVR) in prohibitively high-risk patients such as the above. However, with the advent of